Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 28 | 2025 | 411 | 7.390 |
Why?
|
| Pacemaker, Artificial | 9 | 2025 | 42 | 3.570 |
Why?
|
| Anticoagulants | 8 | 2025 | 143 | 2.080 |
Why?
|
| Atrial Appendage | 4 | 2025 | 24 | 2.050 |
Why?
|
| Stroke | 9 | 2025 | 700 | 2.050 |
Why?
|
| Defibrillators, Implantable | 6 | 2025 | 44 | 2.040 |
Why?
|
| Electrocardiography | 21 | 2023 | 657 | 1.950 |
Why?
|
| Tachycardia, Ventricular | 4 | 2025 | 26 | 1.940 |
Why?
|
| Catheter Ablation | 8 | 2025 | 116 | 1.760 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2025 | 83 | 1.760 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 70 | 1.610 |
Why?
|
| Heart Conduction System | 6 | 2018 | 80 | 1.490 |
Why?
|
| Ventricular Premature Complexes | 3 | 2023 | 20 | 1.460 |
Why?
|
| Electric Countershock | 4 | 2025 | 18 | 1.440 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2023 | 103 | 1.350 |
Why?
|
| Humans | 68 | 2025 | 34562 | 1.180 |
Why?
|
| Heart Failure | 5 | 2020 | 780 | 1.030 |
Why?
|
| Aged | 35 | 2025 | 11022 | 1.010 |
Why?
|
| Male | 49 | 2025 | 20740 | 0.970 |
Why?
|
| Myocardial Infarction | 8 | 2017 | 515 | 0.950 |
Why?
|
| Middle Aged | 38 | 2025 | 12726 | 0.940 |
Why?
|
| Retrospective Studies | 23 | 2025 | 3825 | 0.940 |
Why?
|
| Risk Factors | 24 | 2025 | 4137 | 0.920 |
Why?
|
| Female | 46 | 2025 | 21532 | 0.920 |
Why?
|
| Clinical Alarms | 1 | 2025 | 5 | 0.920 |
Why?
|
| Postoperative Complications | 3 | 2015 | 850 | 0.820 |
Why?
|
| Intensive Care Units | 2 | 2021 | 123 | 0.810 |
Why?
|
| Heart Ventricles | 6 | 2025 | 155 | 0.800 |
Why?
|
| Treatment Outcome | 18 | 2025 | 3623 | 0.790 |
Why?
|
| Septal Occluder Device | 2 | 2025 | 7 | 0.750 |
Why?
|
| Prosthesis-Related Infections | 1 | 2022 | 32 | 0.750 |
Why?
|
| Endocarditis | 1 | 2022 | 23 | 0.750 |
Why?
|
| Intracranial Embolism | 2 | 2025 | 15 | 0.740 |
Why?
|
| Incidence | 9 | 2025 | 1290 | 0.730 |
Why?
|
| Aged, 80 and over | 15 | 2025 | 4157 | 0.720 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 439 | 0.640 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2023 | 13 | 0.630 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2025 | 61 | 0.630 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2020 | 17 | 0.610 |
Why?
|
| Heart-Assist Devices | 1 | 2020 | 53 | 0.600 |
Why?
|
| Mercury | 1 | 2018 | 6 | 0.580 |
Why?
|
| Environmental Pollution | 1 | 2018 | 5 | 0.580 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 4 | 0.580 |
Why?
|
| Environmental Monitoring | 1 | 2018 | 29 | 0.570 |
Why?
|
| Hyperkalemia | 1 | 2018 | 16 | 0.550 |
Why?
|
| Time Factors | 11 | 2025 | 2353 | 0.540 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 18 | 0.540 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2017 | 28 | 0.530 |
Why?
|
| Denervation | 1 | 2017 | 13 | 0.510 |
Why?
|
| Heart Valve Prosthesis | 1 | 2017 | 61 | 0.510 |
Why?
|
| Healthcare Disparities | 2 | 2015 | 183 | 0.470 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 988 | 0.460 |
Why?
|
| Hospitalization | 4 | 2017 | 500 | 0.450 |
Why?
|
| Thromboembolism | 1 | 2015 | 38 | 0.450 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2014 | 4 | 0.440 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 53 | 0.440 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2015 | 184 | 0.420 |
Why?
|
| Coffee | 1 | 2013 | 8 | 0.410 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2013 | 1 | 0.400 |
Why?
|
| Risk Assessment | 9 | 2025 | 1508 | 0.400 |
Why?
|
| Caffeine | 1 | 2013 | 29 | 0.400 |
Why?
|
| Angina Pectoris | 2 | 2023 | 24 | 0.390 |
Why?
|
| Cardiac Output, High | 1 | 2012 | 2 | 0.390 |
Why?
|
| Iliac Vein | 1 | 2012 | 8 | 0.380 |
Why?
|
| United States | 12 | 2020 | 4278 | 0.380 |
Why?
|
| Arteriovenous Fistula | 1 | 2012 | 19 | 0.380 |
Why?
|
| Respiration, Artificial | 1 | 2013 | 105 | 0.380 |
Why?
|
| Iliac Artery | 1 | 2012 | 55 | 0.370 |
Why?
|
| Warfarin | 3 | 2017 | 35 | 0.370 |
Why?
|
| Early Diagnosis | 1 | 2011 | 62 | 0.350 |
Why?
|
| Stroke Volume | 4 | 2023 | 440 | 0.350 |
Why?
|
| Coronary Stenosis | 1 | 2011 | 31 | 0.340 |
Why?
|
| Chest Pain | 3 | 2023 | 232 | 0.340 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 168 | 0.340 |
Why?
|
| Follow-Up Studies | 6 | 2025 | 2367 | 0.320 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2025 | 73 | 0.320 |
Why?
|
| Stents | 1 | 2011 | 167 | 0.310 |
Why?
|
| Atrial Flutter | 3 | 2016 | 20 | 0.310 |
Why?
|
| European Continental Ancestry Group | 4 | 2019 | 1176 | 0.300 |
Why?
|
| Health Status | 1 | 2011 | 411 | 0.300 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 287 | 0.290 |
Why?
|
| Surgical Procedures, Operative | 3 | 2014 | 79 | 0.290 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2008 | 9 | 0.280 |
Why?
|
| Keratitis | 1 | 2008 | 4 | 0.280 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 41 | 0.280 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 32 | 0.280 |
Why?
|
| Medicare | 3 | 2019 | 224 | 0.260 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 542 | 0.250 |
Why?
|
| African Americans | 4 | 2019 | 1435 | 0.250 |
Why?
|
| Brain Ischemia | 2 | 2019 | 160 | 0.250 |
Why?
|
| Equipment Design | 2 | 2023 | 192 | 0.240 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2025 | 9 | 0.230 |
Why?
|
| Heart Rate | 2 | 2025 | 372 | 0.230 |
Why?
|
| Punctures | 1 | 2025 | 35 | 0.230 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 804 | 0.220 |
Why?
|
| Migraine Disorders | 1 | 2025 | 69 | 0.220 |
Why?
|
| Sex Factors | 5 | 2017 | 708 | 0.210 |
Why?
|
| Bundle-Branch Block | 2 | 2015 | 22 | 0.210 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 703 | 0.200 |
Why?
|
| Comorbidity | 3 | 2020 | 596 | 0.200 |
Why?
|
| Phenethylamines | 1 | 2023 | 5 | 0.200 |
Why?
|
| Cohort Studies | 5 | 2020 | 1910 | 0.200 |
Why?
|
| Confidence Intervals | 3 | 2012 | 155 | 0.200 |
Why?
|
| Dyspnea | 2 | 2014 | 36 | 0.200 |
Why?
|
| Pericardial Effusion | 1 | 2023 | 9 | 0.200 |
Why?
|
| HIV Infections | 1 | 2008 | 429 | 0.200 |
Why?
|
| Hypertension | 2 | 2020 | 1024 | 0.190 |
Why?
|
| Artifacts | 1 | 2023 | 47 | 0.190 |
Why?
|
| Methohexital | 1 | 2022 | 7 | 0.190 |
Why?
|
| Propofol | 1 | 2022 | 22 | 0.190 |
Why?
|
| Patient Readmission | 2 | 2015 | 141 | 0.190 |
Why?
|
| Prognosis | 2 | 2020 | 1606 | 0.180 |
Why?
|
| Age of Onset | 2 | 2013 | 95 | 0.180 |
Why?
|
| Emergency Treatment | 2 | 2012 | 42 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 1523 | 0.180 |
Why?
|
| Sinus of Valsalva | 1 | 2021 | 3 | 0.180 |
Why?
|
| Blood Coagulation | 1 | 2021 | 20 | 0.180 |
Why?
|
| Heart Atria | 2 | 2020 | 84 | 0.170 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 803 | 0.170 |
Why?
|
| Heart Septum | 2 | 2025 | 4 | 0.170 |
Why?
|
| Critical Illness | 1 | 2021 | 89 | 0.160 |
Why?
|
| Long QT Syndrome | 1 | 2020 | 44 | 0.160 |
Why?
|
| Hospital Mortality | 1 | 2021 | 207 | 0.160 |
Why?
|
| Atrial Premature Complexes | 1 | 2020 | 22 | 0.150 |
Why?
|
| Adult | 10 | 2017 | 10030 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2020 | 168 | 0.150 |
Why?
|
| Cause of Death | 3 | 2018 | 245 | 0.150 |
Why?
|
| Fossil Fuels | 1 | 2018 | 1 | 0.150 |
Why?
|
| Mining | 1 | 2018 | 1 | 0.150 |
Why?
|
| Rivers | 1 | 2018 | 4 | 0.150 |
Why?
|
| Metals, Heavy | 1 | 2018 | 6 | 0.140 |
Why?
|
| India | 1 | 2018 | 65 | 0.140 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 60 | 0.140 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 261 | 0.130 |
Why?
|
| Pulmonary Veins | 1 | 2017 | 20 | 0.130 |
Why?
|
| Odds Ratio | 3 | 2012 | 480 | 0.120 |
Why?
|
| Brachiocephalic Veins | 1 | 2015 | 7 | 0.120 |
Why?
|
| Echocardiography | 2 | 2018 | 202 | 0.110 |
Why?
|
| Subclavian Vein | 1 | 2015 | 16 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 41 | 0.110 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 305 | 0.110 |
Why?
|
| Dizziness | 1 | 2014 | 9 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2015 | 69 | 0.110 |
Why?
|
| Health Status Disparities | 1 | 2016 | 138 | 0.110 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2012 | 124 | 0.110 |
Why?
|
| Coronary Angiography | 2 | 2012 | 168 | 0.100 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2013 | 2 | 0.100 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2013 | 6 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2012 | 417 | 0.100 |
Why?
|
| Kidney | 1 | 2017 | 528 | 0.100 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2012 | 2 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2012 | 6 | 0.100 |
Why?
|
| Edema | 1 | 2012 | 31 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2012 | 31 | 0.090 |
Why?
|
| Erythema | 1 | 2012 | 25 | 0.090 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 113 | 0.090 |
Why?
|
| Hispanic Americans | 2 | 2015 | 948 | 0.090 |
Why?
|
| Bacteremia | 1 | 2012 | 69 | 0.090 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 87 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 58 | 0.090 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2011 | 8 | 0.090 |
Why?
|
| Physical Exertion | 1 | 2011 | 15 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2012 | 502 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 397 | 0.090 |
Why?
|
| Sympathomimetics | 1 | 2011 | 5 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 19 | 0.090 |
Why?
|
| Methamphetamine | 1 | 2011 | 20 | 0.090 |
Why?
|
| Continental Population Groups | 1 | 2012 | 245 | 0.080 |
Why?
|
| Perioperative Care | 1 | 2011 | 57 | 0.080 |
Why?
|
| Registries | 3 | 2023 | 328 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 52 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 939 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 260 | 0.080 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2010 | 1 | 0.080 |
Why?
|
| Heart Rupture | 1 | 2010 | 3 | 0.080 |
Why?
|
| Lymphoma, T-Cell | 1 | 2010 | 4 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 634 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2022 | 2463 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 1393 | 0.070 |
Why?
|
| Young Adult | 2 | 2017 | 2831 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 70 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 614 | 0.070 |
Why?
|
| Propensity Score | 2 | 2017 | 51 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 823 | 0.060 |
Why?
|
| Patient Admission | 2 | 2017 | 59 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2017 | 213 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2020 | 901 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2017 | 380 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 352 | 0.060 |
Why?
|
| Depression | 1 | 2009 | 458 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 441 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 808 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2015 | 116 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 922 | 0.040 |
Why?
|
| Aorta | 1 | 2021 | 139 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2011 | 88 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2020 | 529 | 0.030 |
Why?
|
| Medicare Part D | 1 | 2017 | 10 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 30 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 109 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 928 | 0.030 |
Why?
|
| Iowa | 1 | 2015 | 9 | 0.030 |
Why?
|
| Phlebography | 1 | 2015 | 27 | 0.030 |
Why?
|
| Ventricular Septum | 1 | 2015 | 1 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 47 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 110 | 0.020 |
Why?
|
| California | 1 | 2013 | 68 | 0.020 |
Why?
|
| Body Surface Potential Mapping | 1 | 2012 | 14 | 0.020 |
Why?
|
| San Francisco | 1 | 2012 | 4 | 0.020 |
Why?
|
| Urban Health Services | 1 | 2012 | 10 | 0.020 |
Why?
|
| Cineradiography | 1 | 2012 | 1 | 0.020 |
Why?
|
| Safety-Based Medical Device Withdrawals | 1 | 2012 | 1 | 0.020 |
Why?
|
| Ambulances | 1 | 2012 | 12 | 0.020 |
Why?
|
| Endocardium | 1 | 2012 | 5 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 176 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 30 | 0.020 |
Why?
|
| Troponin I | 1 | 2012 | 25 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 41 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1262 | 0.020 |
Why?
|
| Device Removal | 1 | 2012 | 44 | 0.020 |
Why?
|
| Running | 1 | 2011 | 21 | 0.020 |
Why?
|
| Telemedicine | 1 | 2013 | 120 | 0.020 |
Why?
|
| Physicians | 1 | 2013 | 169 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 465 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 508 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 140 | 0.020 |
Why?
|
| Research Design | 1 | 2012 | 337 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 189 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 38 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 43 | 0.020 |
Why?
|
| Prevalence | 1 | 2012 | 1034 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 3805 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 197 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 321 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 455 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 806 | 0.010 |
Why?
|